GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,097,391 | -13.3% | 37,024 | +4.7% | 0.01% | -12.5% |
| Q2 2023 | $1,265,494 | +52.4% | 35,349 | -0.2% | 0.01% | +60.0% |
| Q1 2023 | $830,596 | -76.2% | 35,435 | -72.4% | 0.01% | -73.7% |
| Q4 2022 | $3,496,451 | -59.3% | 128,546 | -19.4% | 0.02% | -55.8% |
| Q3 2022 | $8,584,000 | +31.0% | 159,463 | -1.9% | 0.04% | +53.6% |
| Q2 2022 | $6,554,000 | -30.8% | 162,478 | +13.6% | 0.03% | -26.3% |
| Q1 2022 | $9,475,000 | -9.9% | 143,041 | +36.0% | 0.04% | -37.7% |
| Q4 2021 | $10,517,000 | -19.1% | 105,153 | +1.1% | 0.06% | -14.1% |
| Q3 2021 | $12,996,000 | -3.8% | 103,958 | -4.4% | 0.07% | -18.4% |
| Q2 2021 | $13,507,000 | +32.8% | 108,760 | +63.2% | 0.09% | -3.3% |
| Q1 2021 | $10,174,000 | +40.0% | 66,646 | +18.2% | 0.09% | +42.9% |
| Q4 2020 | $7,265,000 | +172.3% | 56,367 | +136.1% | 0.06% | +96.9% |
| Q3 2020 | $2,668,000 | – | 23,871 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |